Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 12, Number 12—December 2006

Research

Evaluating Detection of an Inhalational Anthrax Outbreak

David L. Buckeridge*Comments to Author , Douglas K. Owens†‡, Paul Switzer‡, John Frank§, and Mark A. Musen‡
Author affiliations: *McGill University, Montreal, Quebec, Canada; †Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA; ‡Stanford University, Stanford, California, USA; §University of Toronto, Toronto, Ontario, Canada

Main Article

Figure 2

Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Figure 2. Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO